Skip to main content
Molecule Holdings Inc. logo

Molecule Holdings Inc. — Investor Relations & Filings

Ticker · MLCL ISIN · CA60855E1097 LEI · 529900E2EB85616O9A84 CSE Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2020-11-27 Regulatory Filings
Country CA Canada
Listing CSE MLCL

About Molecule Holdings Inc.

https://molecule.ca/

Molecule Holdings Inc. is a licensed producer specializing in the cannabis beverages sector. The company focuses on the production, packaging, and distribution of a portfolio of quality crafted branded cannabis beverages (CIBs). Recognized for its innovation, Molecule also serves as a comprehensive contract manufacturer and co-packer for the consumer packaged goods market. The company provides essential infrastructure, technology, know-how, and licensing capabilities, enabling craft producers to develop and market various consumable cannabis products, including beverages and edibles. Molecule is noted for being an early entrant, having been the first small-cap company fully dedicated to cannabis beverages to receive its specific processing license.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a supply agreement between Molecule Holdings Inc. and ABcann Medicinals Inc. It details the terms and benefits of the agreement, including the use of Vertosa cannabis emulsions. There is no indication of financial statements, regulatory filings, voting results, or management changes. The content is a corporate announcement about a business agreement, not a financial report or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous corporate news, which corresponds to Regulatory Filings (RNS). The document length is moderate and contains detailed information about the agreement, but it is not a report or presentation. Hence, the classification is RNS with high confidence.
2020-11-27 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Molecule Holdings Inc. It announces a material change regarding the appointment of a new Chief Financial Officer and the resignation of the previous CFO. The document includes a news release attached as Schedule A detailing the appointment. The content focuses on management changes rather than financial results or other report types. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management. The document length is 6170 characters, which is sufficient to be the actual report rather than a brief announcement. Therefore, the correct classification is MANG with high confidence.
2020-11-21 English
News release - English.pdf
Regulatory Filings
2020-11-10 English
News release - English.pdf
Regulatory Filings
2020-10-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release providing an update on production levels, a research agreement, and upcoming investor webinar. It contains no detailed financial statements, quarterly or annual results, or regulatory filings. It is primarily an operational and corporate update with forward-looking statements and investor communication. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general corporate announcement aimed at investors and the public, typical of a Regulatory Filing (RNS) as a miscellaneous announcement that does not fit other specific categories.
2020-10-15 English
News release - English.pdf
Regulatory Filings
2020-10-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.